BIOBANCO CELULAR 

The future in a smile

OWNER

Pil Puig (See Profile)

Sector

Biotech

Stage

Sales, licensing phases

Country

Spain

Propietary knowHow and patented technology that allow high quality and viability of the cryopreserved stemcells

The biobanking market is expected to rise from USD 1.72 Billion in 2016 to USD 2.69 Billion by 2022 at a CAGR of 7.8%. The base year for this study was 2016

Our processing platform is really cost effective and that makes that our prices are in the medium-low range.

This information is confidential, do not share or copy.

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

CONTACT US

Hi! Any doubts? Send us a message and we'll get back to you, asap.

Sending

©2018 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACCEPT
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar